Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S381000, C548S252000, C548S260000
Reexamination Certificate
active
07960417
ABSTRACT:
The present invention is directed to benzazole compounds which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.
REFERENCES:
patent: 4096267 (1978-06-01), Cragoe et al.
patent: 4177285 (1979-12-01), Cragoe et al.
patent: 4182764 (1980-01-01), Cragoe et al.
patent: 4874775 (1989-10-01), Krumkalns et al.
patent: 4983628 (1991-01-01), Frenette et al.
patent: 6380218 (2002-04-01), Marfat et al.
patent: 6482834 (2002-11-01), Spada et al.
patent: 2002/0006948 (2002-01-01), Halfbrodt et al.
patent: 1403255 (2004-03-01), None
patent: WO 01/56990 (2001-08-01), None
patent: 2004018386 (2004-03-01), None
patent: WO 2004/018386 (2004-03-01), None
patent: 2004108686 (2004-12-01), None
patent: WO 2006/014918 (2006-02-01), None
patent: WO 2006/015158 (2006-02-01), None
patent: WO 2006/047237 (2006-05-01), None
patent: WO 2006/049968 (2006-05-01), None
O. W. Woltersdorf et al., “(Acylaryloxy) Acetic Acid Diuretics. 1. (2-Alkyl-and 2,2-Dialkyl-1-Oxo-5-Indanyloxy) Acetic Acids” , J. of Medicinal Chemistry, 1977, vol. 20. No. 11, pp. 1400-1408.
S. J. deSolms et al., “(Acylaryloxy) Acetic Acid Diuretics. 2. (2-Alkyl-2-Aryl-1-oxo-5 Indanyloxy) Acetic Acids”, J. of Medicinal Chemistry, 1978, vol. 21, No. 5, pp. 437-443.
M. P. Johnson et al., “Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor: Synthesis and Subtype Selectivity of N-(4-(2-Methoxyphenoxy)phenyl)-N(2,2,2-Trifluoroethylsulfonyl) Pyrid-3-Ylmethyl-Amine”, J. Med. Chem., 2003, vol. 46, pp. 3189-3192.
A. B. Pinkerton et al., “Allosteric Potentiators of the Metabotropic Glutamate Receptor 2 (mGlu2). Part 1: Identification and Synteheis of Phenyl-Tetrazolyl Acetophenones”, Bioorganic & Medicinal Chemistry Letters, 2004, vol. 14, pp. 5329-5332.
A. B. Pinkerton et al., “Allosteric Potentiators of the Metabotropic Glutamate Receptor 2 (mGlu2). Part 2: 4-Thiopyridyl Acetophenones as Non-Terazole Containing mG1u2 Receptor Potentiators”, Bioorganic & Medicinal Chemistry Letters, 2004, vol. 14, pp. 5867-5872.
A. B. Pinkerton et al., A. B. Pinkerton et al., “Allosteric Potentiators of the Metabotropic Glutamate Receptor 2 (mGlu2). Part 3: 4-Thiopyridyl Acetophenones as Non-Terazole Containing mGlu2 Receptor Potentiators”, Bioorganic & Medicinal Chemistry Letters, 2005, vol. 15, pp. 1565-1571.
Susumu Igarashi, et al., ‘A novel class of inhibitors for human steroid 5-alpha-reductase: synthesis and biological evaluation of indole derivatives’, Chemical and Pharmaceutical Bulletin, vol. 48, No. 3, 2000, pp. 382-388.
Susumu Igarashi, et al., ‘A novel class of inhibitors for human and rat steroid 5-alpha-reductases: synthesis and biological evaluation of indole and aniline derivatives’, Chemical and Pharmaceutical Bulletin, vol. 48, No. 11, 2000, pp. 1689-1697.
Alan D. Adams, et al., ‘Amphipathic 3-phenyl-7-propylbenzisoxazoles; human PPAR gamma, delta and alpha agonists’, Bioorganic & Medicinal Chemistry Letters, vol. 13, No. 5, 2003, pp. 931-935.
Steven P. Govek, et al., ‘Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia’, Bioorganic & Medicinal Chemistry Letters, vol. 15, No. 18, 2005, pp. 4068-4072.
Youhua Yang and Arnold R. Martin, ‘Synthesis of 5-arylated indoles via palladium-catalyzed cross-coupling reaction of 5-indolylboronic acid with aryl and heteroaryl halides’, Heterocycles, vol. 34, No. 7, 1992, pp. 1395-1398.
Mark T. Bilodeau, et al., ‘Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR’, Bioorganic & Medicinal Chemistry Letters, vol. 13, 2003, pp. 2485-2488.
Eckhard Baston & Rolf W. Hartmann, ‘N-substituted 4-(5-indolyl)benzoic acids synthesis and evaluation of steriod 5 alpha-reductase type I and II inhibitory activity’, Bioorganic & Medicinal Chemistry Letters, vol. 9, No. 11, 1999, pp. 1601-1606.
C. W. Schellhammer, et al., ‘Uber alkylierungen von benzotriazol-derivaten’, Tetrahedron, vol. 26, No. 2, 1970, pp. 497-510.
Wayne K. Anderson, et al., ‘Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents’, Journal of Medicinal Chemistry, vol. 37, No. 13, 1994, pp. 1955-1963.
Supplementary Partial European Search Report for PCT/US2006/005711, mailed Apr. 6, 2010.
Govek Steven P.
Hutchinson John H.
Kamenecka Theodore
Pracitto Richard
Vernier Jean-Michel
Devlin Gerard
Merck Sharp & Dohme Corp.
Morris Patricia L
Yuro Raynard
LandOfFree
Benzazole potentiators of metabotropic glutamate receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzazole potentiators of metabotropic glutamate receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzazole potentiators of metabotropic glutamate receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2657555